TW up +1.02% percent right now. $TW High is at 114.74 and

New Post Public Reply Private Reply Replies (0) Message Board
Lucky Jimmy
TW up +1.02% percent right now. $TW High is at 114.74 and the Low 112.95 with current volume of 491,400.

Recent News posted below.

TW Towers Watson & Co Recent Headline News

Company News for November 06, 2014 - Corporate Summary
Zacks Equity Research - Zacks Investment Research - Thu Nov 06, 9:10AM CST
Companies in the News are: ACT,CTSH,COV,TW
ACT: 245.91 (-4.47), COV: 92.08 (-0.52), CTSH: 53.62 (+0.98), TW: 114.66 (+1.16)

Multinational Pooling Arrangements Deliver Strong Profits
Business Wire - Thu Nov 06, 8:05AM CST
Global companies that operate multinational pooling arrangements generated annual average returns of 6.1% on the financial performance of their pooling arrangements, according to a new research study conducted by global professional services company Towers Watson (NYSE, NASDAQ: TW). The study analyzed 753 multinational pooling reports from 151 international companies comprising $2.4 billion in premiums and found that nearly two-thirds (64%) of the multinational pools analyzed returned positive dividends.*
TW: 114.66 (+1.16)

Towers Watson Announces New Team Edition for RiskAgility FM
Business Wire - Thu Nov 06, 8:05AM CST
Global professional services company Towers Watson (NYSE, NASDAQ: TW) today introduced a new edition of its RiskAgility FM risk and capital modeling solution for life insurers worldwide. Incorporating all the features of the Standard edition, the Team edition adds functionality to provide for improved management, governance and auditability of financial models through new version management, user access control and collaboration tools.
TW: 114.66 (+1.16)

Towers Watson (TW) Stock Higher Today After 2015 First Quarter Earnings Results
at The Street - Wed Nov 05, 10:24AM CST
Shares of Towers Watson (TW) are up today after reporting 2015 first quarter revenue increased 8% from a year ago and earnings beat expectations.
TW: 114.66 (+1.16)

Towers Watson tops Street 1Q forecasts
Automated Insights - Wed Nov 05, 5:24AM CST
ARLINGTON, Va. (AP) _ Towers Watson & Co. (TW) on Wednesday reported net income of $81.6 million in its fiscal first quarter.
TW: 114.66 (+1.16)

Towers Watson Reports Strong First Quarter Earnings
Business Wire - Wed Nov 05, 5:00AM CST
--EBITDA Margin increased to 19.5%, from 18.0% for the prior year first quarter
TW: 114.66 (+1.16)

Many U.S. Companies Performed Executive Pay-for-Performance Analyses but Did Not Disclose in 2014 Proxies, Towers Watson Survey Finds
Business Wire - Thu Oct 30, 8:05AM CDT
Six in 10 U.S. public companies have conducted analyses to assess how closely their executive pay levels align with company performance. However, nearly two-thirds of those companies did not disclose the results of those analyses in their 2014 proxy statements, mostly because they are awaiting soon-to-be-released pay-for-performance disclosure guidance from the Securities and Exchange Commission (SEC), according to a new survey by global professional services company Towers Watson (NYSE, NASDAQ: TW).
TW: 114.66 (+1.16)

Towers Watson Introduces Updated Version of ResQ Reserving Software
Business Wire - Wed Oct 29, 8:05AM CDT
Global professional services company Towers Watson (NYSE, NASDAQ: TW) has released an updated version of its ResQ reserving software for property & casualty (P&C) insurers, which includes enhanced methods to allow insurers to quantify possible inflationary and other calendar-related effects.
TW: 114.66 (+1.16)

Career Management Programs Missing the Mark, Towers Watson Research Finds
Business Wire - Mon Oct 27, 8:05AM CDT
Career management programs are supposed to help employees understand advancement opportunities and chart career paths with their organizations. However, research from global professional services company Towers Watson (NYSE, NASDAQ: TW) reveals that employers and employees alike agree that career management programs are largely failing to meet these goals. This finding comes at a time when many employees believe their careers are stuck in neutral and say they would need to leave their employer to advance their careers.
TW: 114.66 (+1.16)

Towers Watson Launches Global Not-for-Profit Thinking Ahead Institute
Business Wire - Wed Oct 22, 11:22AM CDT
Global professional services company Towers Watson (NYSE, NASDAQ: TW) announced it is launching a global not-for-profit Thinking Ahead Institute with the aim of influencing change in the investment world to improve the provision of savings. The Institute is open to asset owners, investment managers and other groups that are motivated to influence the industry for the good of savers worldwide, and already has 19 members from Australia, France, South Africa, the U.K. and the U.S., with total assets of $5.6 trillion. The Thinking Ahead Institute is an outgrowth of the company's Thinking Ahead Group established by Roger Urwin and Tim Hodgson in 2002.
TW: 114.66 (+1.16)

Towers Watson Foresees Moderate Global Growth With Downside Risk
Business Wire - Tue Oct 21, 8:05AM CDT
In its Secular Outlook 2014: Investing Under a Cloud, Towers Watson (NYSE, NASDAQ: TW) concludes overall global growth in the next three to five years will be moderate and divergent on a country basis, and risks to global growth are skewed to the downside. The paper also indicates that Germany and the U.S. have reasonable medium-term growth drivers, but that the U.K. remains heavily indebted and sensitive to interest rate increases. The rest of Europe and Japan are in a difficult economic environment and in danger of remaining in a negative situation of low interest rates, weak growth and low inflation, according to the company. The report says a combination of gradual but significant currency appreciation and rapid increases in wages means Chinese labor is now materially less competitive than it was five years ago and will grow at a much slower pace over the next decade compared to the past 10 years.
TW: 114.66 (+1.16)

Towers Watson to Announce First Quarter Fiscal 2015 Earnings on November 5, 2014
Business Wire - Thu Oct 16, 4:20PM CDT
Towers Watson & Co. (NYSE, NASDAQ: TW), a global consulting firm, will announce its financial results for the first quarter of fiscal 2015 on Wednesday, November 5, 2014 before the market opens.
TW: 114.66 (+1.16)

Towers Watson's OneExchange for Active Employees Holds Health Care Cost Increases for Employers to Just 1.8% in 2015
Business Wire - Wed Oct 08, 8:05AM CDT
Towers Watson (NYSE, NASDAQ: TW) announced today that total spending on health care by employers participating in Towers Watson's OneExchange private exchange solution for active employees is projected to grow by just 1.8% from 2014 to 2015. Total spending includes funding for coverage from employers as well as employee contributions and out-of-pocket costs.
TW: 114.66 (+1.16)

Cash Bonuses Important in M&As, but Only Part of Equation to Retain Key Talent
Business Wire - Wed Oct 08, 8:05AM CDT
Creating the ideal employee retention strategy remains elusive for companies that have recently completed either a merger or acquisition and exercised employee retention agreements, according to a new survey by global professional services company Towers Watson (NYSE, NASDAQ: TW). The 2014 Global M&A Retention Study examined the tactics applied by employers during a transaction to retain key staff, and assessed the effectiveness of retention agreements.
TW: 114.66 (+1.16)

P&C Insurers Say Capital Utilization Is Top Priority
Business Wire - Tue Oct 07, 8:52AM CDT
Chief financial officers (CFOs) from North American property & casualty (P&C) insurance companies identified capital utilization as their top business priority, according to a new P&C insurance CFO survey conducted by global professional services company Towers Watson (NYSE, NASDAQ: TW). The CFOs cited preparing for the Own Risk and Solvency Assessment (ORSA) requirements and monitoring progress toward the renewal of the U.S. Terrorism Risk Insurance Act (TRIA) as their next highest priorities.
TW: 114.66 (+1.16)

Towers Watson Launches Service for Employers That Subsidize Early Retiree Health Benefits
Business Wire - Tue Oct 07, 8:05AM CDT
Global professional services company Towers Watson (NYSE, NASDAQ:TW) today announced a personalized decision support service that will help early retirees determine whether they are better off using a subsidy from their former employer or taking a tax credit from the federal government. Employer clients of Towers Watson's OneExchange asked for this capability in order to facilitate moving their early (pre-Medicare) retiree populations to individual market plans.
TW: 114.66 (+1.16)

Towers Watson & Co Rises 1.11% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Oct 06, 4:56PM CDT
Towers Watson & Co (NYSE:TW) traded in a range yesterday that spanned from a low of $102.00 to a high of $103.25. Yesterday, the shares gained 1.1%, which took the trading range above the 3-day high of $102.81 on volume of 522,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TW: 114.66 (+1.16)

Ohio Public Employees Retirement System Selects a Towers Watson Company to Administer OPERS Medicare Connector
Business Wire - Wed Oct 01, 9:36AM CDT
The Ohio Public Employees Retirement System (OPERS) has selected Extend Health, Inc., a Towers Watson (NYSE, NASDAQ: TW) company, to deliver and manage a private Medicare exchange, or connector, for its 145,000 Medicare-eligible retirees and spouses beginning in 2016. The OPERS Medicare Connector will use Towers Watson's OneExchange (formerly the Extend Health Medicare exchange) to provide retirees with access to plans on the individual Medicare market, one of several changes adopted by OPERS to offer more health care plan choices at affordable prices.
TW: 114.66 (+1.16)

U.S. Employers Looking to Enhance 401(k) Investment Structures, Towers Watson Survey Finds
Business Wire - Tue Sep 30, 8:05AM CDT
With millions of workers now relying on 401(k) plans as their primary retirement savings vehicle, U.S. employers are enhancing the investment structures of those plans, according to a new survey by global professional services company Towers Watson (NYSE: NASDAQ: TW). This includes replacing single, stand-alone investment options with multi-manager, white-label choices, implementing custom target-date fund (TDF) solutions and outsourcing all or portions of their 401(k) plan oversight.
TW: 114.66 (+1.16)

Nearly One in Four Employers Say Private Health Insurance Exchanges Could Provide a Viable Alternative for Full-Time Active Employees in 2016
Business Wire - Thu Sep 25, 8:05AM CDT
Results of a July 2014 survey of midsize to large employers by global professional services company Towers Watson (NYSE, NASDAQ:TW) showed that 28% said they had already extensively evaluated the viability of private exchanges. Nearly one in four (24%) said private exchanges could provide a viable alternative for their active full-time employees as soon as 2016.
TW: 114.66 (+1.16)
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Dr. Boonipat Inspires Future Women Surgeons at Texas Tech

Updated Category News Views 75

Sowing Surgical Seeds in Lubbock In Lubbock, Texas, something meaningful unfolded—an event the big market players would hardly blink at, but a significant step for the future of medicine. Led by Dr. Thanapoom "Mo" Boonipat, the founder of FacePlus Plastic Surgery Institute, a unique suturing workshop provided premed students at Texas Tech University hands-on experience...

Continue Reading
Hims & Hers Faces FTC Heat: Investor Class Action Looms

Updated Category News Views 176

Trouble Is Brewing for Hims & Hers Investors This isn't your typical quiet stroll through the park when it comes to Hims & Hers Health, Inc. (NYSE: HIMS). We're talking about a full-blown legal showdown that's unfolding faster than you can say 'telehealth scandal.' October 25, 2026, saw the kind of announcement that makes seasoned investors' hearts skip a beat if they've...

Continue Reading
Kelun-Biotech's Sacituzumab Tirumotecan Shows Promise in NSCLC

Updated Category News Views 324

Kelun-Biotech's Recent Breakthrough Grab your coffee, and let's chat about something that might just change the lung cancer treatment game: Kelun-Biotech's sacituzumab tirumotecan, or sac-TMT, showing some serious promise in a Phase III trial. With numbers that could make any investor sit up a little straighter, this study has turned heads at the European Society for...

Continue Reading
Wenda Pharma's NHWD-870 HCl Shows Promise in Trial

Updated Category News Views 393

Breaking Through in NUT Carcinoma Treatment Imagine battling an aggressive disease with barely any options left, and then something hopeful shows up in the pipeline. That's the story with Zhejiang Wenda Pharma's NHWD-870 HCl, an oral BET inhibitor making waves at the 2026 ESMO Annual Meeting. Facing off against the nasty beast that is NUT carcinoma, this drug didn't just...

Continue Reading
BAIC FOTON Eyes African Market with Strategic Moves

Updated Category News Views 90

Revving Up for Africa Alright, gearheads and number-crunchers, strap in. BAIC FOTON is making headlines again, and this time they’re zooming right into Africa—like they're claiming pole position on a circuit that's been ignored by many. They’re calling it a “Drive to Great!” but what does that mean for us investors who aren’t just in it for the entertainment?...

Continue Reading
Survivors Secure $800M Settlement with NY Archdiocese

Updated Category News Views 345

Massive Settlement: A Long-Awaited Justice Here's a different kind of news that's hitting like a thunderbolt. Over 1,300 survivors of abuse have finally struck a landmark deal with the Archdiocese of New York. Not only are the numbers staggering, but the relief for these individuals is palpable. We're talking about more than $800 million on the table here. That's some...

Continue Reading
Johnson & Johnson's JNJ-6143 Shines in Prostate Cancer Study

Updated Category News Views 249

Prostate Cancer's Persistent Challenge No one in the healthcare game needs the reminder: prostate cancer is no walk in the park, especially for those grappling with advanced stages. Now picture this—you're on your sixth treatment, and the cloud is not lifting. It's a battle that never ends, with traditional therapies sometimes barely holding the line. JNJ-6143's New...

Continue Reading
Sinclair Faces Labor Lawsuit for Break-time Violations

Updated Category News Views 199

Sinclair Television Caught in Labor Law Storm When you think of flaring tempers and boardroom brawls, you typically don't think of your everyday TV station. But right now, Sinclair Television of California, LLC is in the hot seat, accused of playing fast and loose with wage packets—specifically, allegedly denying meal periods and rest breaks that California labor laws...

Continue Reading
Miranda Lambert Lights Up Red Kettle Campaign

Updated Category News Views 209

A Star-Studded Start to the Season of Giving Miranda Lambert is set to dazzle audiences yet again, and if there's one thing this country music titan knows, it's how to crank up the heartstrings while fanning the flames of generosity. She'll take to the stage at AT&T Stadium this Thanksgiving during the Dallas Cowboys game, bringing a powerful performance to light up the...

Continue Reading
Lilly's Olomorasib: New Data Sparks Hope for G12C NSCLC

Updated Category News Views 186

New Data Unveiling Potential Shifts in NSCLC Treatment Man, if there's one thing the oncology world craved, it's progress against KRAS G12C-mutant non-small cell lung cancer (NSCLC). We're talking about a challenge as tough as a two-dollar steak. But hey, Eli Lilly's (NYSE:LLY) putting some serious cards on the table with olomorasib, and folks at the ESMO 2026 Congress...

Continue Reading

Top 5 Most Recently Viewed Articles

Earnings Forecast and Expectations for Anika Therapeutics

Updated Category News Views 118

Understanding Anika Therapeutics's Upcoming Earnings Anika Therapeutics (NASDAQ: ANIK) is scheduled to unveil its quarterly earnings report soon. This anticipation is palpable amongst investors who are eager to discover the latest financial insights that the company has to offer. As the date approaches, many are analyzing the potential earnings and what they might mean...

Continue Reading
QYOU Media's Strategic Shift Towards a Creator-Focused Future

Updated Category News Views 202

QYOU Media Completes Sale of Q TV Broadcast Channel QYOU Media Inc., a leading player in the global creator economy, has successfully completed the sale of its free-to-air broadcast channel known as Q TV. This strategic move, executed through its subsidiary QYOU Media India Pvt. Ltd., marks a significant shift towards embracing new growth avenues focused on social media...

Continue Reading
Understanding Recent Disclosures from Octopus Investments

Updated Category News Views 106

Key Disclosure Information by Octopus Investments PUBLIC DISCLOSURE OF INVESTMENT INTERESTS In line with market regulations, Octopus Investments Ltd reveals crucial data regarding interests in relevant securities, particularly concerning Marlowe plc. This disclosure adheres to Rule 8.3 of the Takeover Code, aimed at maintaining transparency in the investment community....

Continue Reading
LiTime's Innovative Battery Solutions Shine in European RV Market

Updated Category News Views 297

LiTime Introduces H190 Series Batteries for RV Enthusiasts At a recent trade show, LiTime made quite the impression with its first participation in Europe’s premier RV exhibition, the Il Salone del Camper. The event, which boasts a large turnout, allowed the company to spotlight its innovative H190 series of batteries tailored for motorhomes. Targeted Designs for Unique...

Continue Reading
Oncolytics Biotech Appoints Jared Kelly as New CEO to Lead Growth

Updated Category News Views 263

Oncolytics Biotech Welcomes New Leadership for Future Growth Oncolytics Biotech Inc. (NASDAQ: ONCY), a notable player in the clinical-stage biotechnology sector focused on immunotherapy for cancer treatment, has proudly appointed Jared Kelly as its new Chief Executive Officer and as a member of its Board of Directors. This significant transition marks a pivotal moment for...

Continue Reading